Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001877291-25-000003
Filing Date
2025-02-12
Accepted
2025-02-12 17:26:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4142
  Complete submission text file 0001877291-25-000003.txt   5780
Mailing Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6
Business Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6 6046221186
BIOHARVEST SCIENCES INC. (Subject) CIK: 0001723464 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94858 | Film No.: 25616177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 MICHAEL NE'EMAN APT 28 TEL AVIV L3 6958109
Business Address
Rakib Vivien (Filed by) CIK: 0002056444 (see all company filings)

Type: SCHEDULE 13G